Dear Editor,
Trichosporonosis, which emerged as an infectious disease in the past two decades, has become increasingly common in immunocompromised patients owing to the increasing number of antifungal agents used. Predisposing factors include malignancy, acquired immunodeficiency syndrome, organ transplantation, corticosteroid therapy, and hemodialysis.
1À3, 5 Herein, we present the case of a female patient complicated with end stage renal disease with systemic calciphylaxis complicating necrotizing fasciitis ( Fig. 1A and B) who developed a breakthrough Trichosporon asahii infection while receiving anidulafungin therapy for invasive candidiasis caused by C. tropicalis.
A 48-year-old woman was admitted to our hospital because of left diabetic foot infection with gangrene. She had uremia and underwent hemodialysis regularly for 8 years. She also had calciphylaxis (calcific uremic arteriolopathy) (Fig. 1A) due to tertiary hyperparathyroidism. Growth of vancomycin-resistance Enterococcus faecium (VRE), Aeromonas caviae, and Stenotrophomonas maltophilia was noted in the left foot wound culture sample obtained upon admission. An antibiotic regimen with tigecycline 200 mg stat and 50 mg intravenously drip (ivd) every 12 h (q12h), plus ceftazidime 2 g ivd q24h, was administered. Computed tomography with angiography revealed diffuse calcification on the below knee arteries and total occlusion in the calcification site at the lateral circumflex femoral artery. After discussing with cardiovascular and orthopedic surgeons, left side above knee amputation for the progressive necrotizing fasciitis was performed on the 10th day of hospitalization. The pathologic report on the amputated part revealed a milky material discharge ( Fig. 1A and B) , and fungal yeast in necrotic soft tissue. The wound tissue culture revealed C. tropicalis at the 8th admission day. She received the antifungal agent with anidulafungin 200 mg ivd stat and 100 mg ivd q24h for C. tropicalis infection. The wound/tissue culture was performed again at the 22th admission day due to the inflammation of the stump area became worsen. Growth of T. asahii colonies with a creamy, grayewhite color morphology (Fig. 1C) was noted on the blood agar plate culture after 14 days of anidulafungin therapy. The Gram stain of T. asahii revealed pigmented yeast-like micro-organisms (Fig. 1D) . The organism was identified by matrixassisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS Biotyperä, Bruker Daltonik GmbH, Bremen, Germany) with an identification score value of 2.166. Therefore, combination antibiotic therapy with intravenous linezolid, ceftazidime, sulbactam, voriconazole, and colistin were administered. In accordance with the patient's critical condition, she received surgical debridement over the left amputation stump wound 3 times due to poor wound healing. Moreover, the patient developed hypotension after the operation and received inotropes to maintain her blood pressure. A follow-up blood test revealed progressive leukocytosis with neutrophil predominance, and poor surgical wound healing was observed. Growth of carbapenem-resistant Acinetobacter baumannii in the surgical wound culture was noted on the 28th day of hospitalization. Unfortunately, the patient had a sudden cardiac arrest and died 24 h after the culture result was released.
Disseminated trichosporonosis has contributed to a high rate of morbidity and mortality, which may reach 100% in patients with persistent neutropenia.
1e4 Trichosporon species are resistant to flucytosine, while echinocandins and amphotericin B has been showed to have limited activity in vivo. 5, 6 In general, Trichosporon species isolates are less susceptible to echinocandin agents (caspofungin, micafungin, and anidulafungin), similar to Zygomycetes, Rhodotorula species, and Cryptococcus species because of the lack of 1,3-b-D glucan in the cell wall. As a result, patients with breakthrough fungal infections caused by these organisms during the use of echinocandins have been reported. 2e4 Another study in Japan 6 reported that the mechanisms for drug-resistance of Trichosporon species may be the same as the mechanisms found in Candida and Aspergillus species, namely modification of target molecules or decrease of access to the molecules. However, the optimal treatment for breakthrough trichosporonosis is yet to be established.
In conclusion, more cases have been reported recently on breakthrough T.asahii infections in patients receiving echinocandins therapy. 2, 4 A large scale surveillance in Asia showed that Cryptococcus and Trichosporon species were the leading two non-Candida yeasts isolated from blood samples. 7 However, studies for identifying the optimal treatment are still lacking. 2, 4 However, previous studies revealed that new azole drugs (voriconazole) showed significant activity against Trichosporon species.
3 However, prompt administration of antifungal drugs is a major concern in modern therapeutic modalities and invasive procedure for critically ill patients. 
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